Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
Open Access
- 24 October 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (59) , 100113-100127
Abstract
Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancerKeywords
This publication has 84 references indexed in Scilit:
- Metformin, at Concentrations Corresponding to the Treatment of Diabetes, Potentiates the Cytotoxic Effects of Carboplatin in Cultures of Ovarian Cancer CellsReproductive Sciences, 2013
- Cancer cell metabolism: implications for therapeutic targetsExperimental & Molecular Medicine, 2013
- LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug PhenforminCancer Cell, 2013
- Phenformin as prophylaxis and therapy in breast cancer xenograftsBritish Journal of Cancer, 2012
- Dissecting “PI3Kness”: The Complexity of Personalized Therapy for Ovarian CancerCancer Discovery, 2012
- Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and ChemosensitivityObstetrics & Gynecology, 2012
- Dietary energy availability affects primary and metastatic breast cancer and metformin efficacyBreast Cancer Research and Treatment, 2009
- Body mass index and risk of ovarian cancerCancer, 2009
- Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient miceBiochemical Journal, 2008
- Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort studyBMJ, 2007